HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

194.500

+6.8003.62%

Volume:708.54K

Turnover:135.96M

Market Cap:17.67B

PE:-4.89

High:198.300

Open:189.200

Low:182.300

Close:187.700

52wk High:563.500

52wk Low:158.500

Shares:90.82M

HK Float Shares:90.82M

Volume Ratio:0.73

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-39.800

ROE:-1282.14%

ROA:-9.61%

PB:6.24

PE(LYR):-4.89

PS:8.18

Loading ...

Overview Company News Filings

Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech

Bulletin Express

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress

DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant

Bulletin Express

Duality Biotherapeutics shareholders approved RMB share issue plan at EGM

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress

DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正

Bulletin Express

DualityBio publishes 2025 ESG report

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

Stock Track | DUALITYBIO-B Soars 5.02% Intraday on STAR Market Listing Plan Announcement

DualityBio-B Advances Global ADC Leadership with Dual Capital Platform Strategy

DualityBio Convenes 29 April 2026 EGM to Approve RMB Share Issue and Corporate Governance Amendments

Bulletin Express

Duality Biotherapeutics announces extraordinary general meeting

DualityBio Proposes Up to RMB 6.75 Billion STAR Market IPO; Shareholders to Vote on 29 April 2026

Bulletin Express

BRIEF-Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board

DUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan

Duality Biotherapeutics Inc - Proceeds Raised From RMB Share Issue Will Be Used for Innovative Drug Research, Others

THOMSON REUTERS

Duality Biotherapeutics Inc - Approved Proposed RMB Share Issue on Sci-Tech Board

THOMSON REUTERS

Duality Biotherapeutics Inc - Proposes to Issue Not More Than 15.8 Mln RMB Shares

THOMSON REUTERS

DualityBio says China NMPA accepts trastuzumab pamirtecan breast cancer BLA for review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/09606/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":194.5,"timestamp":1787299688006,"preClose":187.7,"halted":0,"volume":708535,"delay":0,"changeRate":0.03622802344166229,"floatShares":90824200,"shares":90824200,"eps":-39.8,"marketStatus":"Market Closed","change":6.8,"latestTime":"08-21 16:08:08","open":189.2,"high":198.3,"low":182.3,"amount":135955619,"amplitude":0.085242,"askPrice":194.6,"askSize":600,"bidPrice":194.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-31.631,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":187.7,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.7250757174044793,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90824200,"roa":"-9.61%","roe":"-1282.14%","lyrEps":-39.8,"volumeRatio":0.7250757174044793,"shares":90824200,"dividePrice":0,"high":198.3,"amplitude":0.085242,"preClose":187.7,"low":182.3,"week52Low":158.5,"pbRate":"6.24","psRate":"8.18","week52High":563.5,"institutionHeld":0,"latestPrice":194.5,"committee":-0.5,"eps":-39.8,"divideRate":0,"volume":708535,"delay":0,"ttmEps":-31.631,"open":189.2,"prevYearClose":298.2,"prevWeekClose":192.6,"prevMonthClose":181.8,"prevQuarterClose":181.2,"fiveDayClose":192.6,"twentyDayClose":234.2,"sixtyDayClose":223,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1783440000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-08-21","current":-6.149031,"percent":0.906627,"low":-29.984477,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"high":-4.703556,"avg":-11.684236,"sd":6.231586,"marketCap":17593072323},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838},{"date":"2026-06-05","current":-5.374082,"twenty":-18.0452,"median":-9.575685,"eighty":-8.511806,"marketCap":16873830092},{"date":"2026-06-12","current":-5.36331,"twenty":-17.183112,"median":-9.557279,"eighty":-8.481744,"marketCap":16828616185},{"date":"2026-06-18","current":-5.321722,"twenty":-16.860136,"median":-9.537613,"eighty":-8.412993,"marketCap":16738188371},{"date":"2026-06-26","current":-4.703556,"twenty":-16.761475,"median":-9.522579,"eighty":-8.375473,"marketCap":14721648119},{"date":"2026-07-03","current":-6.212828,"twenty":-16.718804,"median":-9.508222,"eighty":-8.310046,"marketCap":19460065572},{"date":"2026-07-10","current":-6.457487,"twenty":-16.608112,"median":-9.462457,"eighty":-8.218812,"marketCap":20201573647},{"date":"2026-07-17","current":-6.192643,"twenty":-16.533051,"median":-9.445101,"eighty":-8.097368,"marketCap":19441980010},{"date":"2026-07-24","current":-6.744145,"twenty":-16.505793,"median":-9.428231,"eighty":-7.995787,"marketCap":21178194038},{"date":"2026-07-31","current":-5.225281,"twenty":-16.472851,"median":-9.409879,"eighty":-7.856069,"marketCap":16439776585},{"date":"2026-08-07","current":-5.555188,"twenty":-16.434203,"median":-9.398864,"eighty":-7.73561,"marketCap":17511664790},{"date":"2026-08-14","current":-5.519506,"twenty":-16.417169,"median":-9.342917,"eighty":-7.473767,"marketCap":17421211976},{"date":"2026-08-21","current":-5.561665,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"marketCap":17593072323}],"updateTime":1787476991967},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104659656","title":"Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1104659656","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104659656?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:22","pubTimestamp":1778624576,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (Duality Biotherapeutics) has formally exercised its exclusive cost and profit/loss sharing option for the antibody-drug conjugate (ADC) DB-1311/BNT324 in the United...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166588783","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166588783","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166588783?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:30","pubTimestamp":1778477425,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","02137","03347","09688","09995","06978","02269","06606","09606","02268","09966","02359","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103858173","title":"DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1103858173","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103858173?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151794,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio-B) filed its monthly return for the period ended 30 April 2026, highlighting incremental equity issuance driven by option exercises while maintaining...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513242","title":"Duality Biotherapeutics shareholders approved RMB share issue plan at EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513242?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:32","pubTimestamp":1777462356,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics held an extraordinary general meeting on April 29, 2026, passing all resolutions put to shareholders.Shareholders authorized a proposed RMB Share Issue, granting a specific mandate for the issuance.Board received authority to handle matters relating to RMB Share Issue, including related implementation steps.Shareholders endorsed plans tied to RMB Share Issue, including a three-year RMB share price stabilization plan, a three-year dividend return plan, a plan to address accumulated unrecovered losses, use of proceeds, and measures to mitigate dilution of immediate returns.Meeting adopted new procedural rules for shareholder general meetings and board meetings, approving amendments to articles of association, with effectiveness tied to date of listing of RMB Shares on Sci-Tech Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL35HBcs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","LU2543165471.USD","09606","HK0000252160.HKD","BK1161","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124616358","title":"HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124616358","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124616358?lang=en_us&edition=fundamental","pubTime":"2026-04-28 10:06","pubTimestamp":1777342004,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. Wuxi Apptec soared 14% as 1Q net profit rose 26.7%; Junshi Bio up 8%; Asymchem up nearly 7%; Wuxi XDC up 5%; Pharmaron up 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","02268","09995","03347","09966","06978","03759","01672","09688","02359","02137","06606","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164489207","title":"DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正","url":"https://stock-news.laohu8.com/highlight/detail?id=1164489207","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164489207?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:26","pubTimestamp":1777202773,"startTime":"0","endTime":"0","summary":"根据公告资料，Duality Biotherapeutics（简称“DUALITYBIO-B”）于2025年实现全年收入约18.52亿元，同比下降4.6%。公司聚焦新一代抗体偶联药物（ADC）研发，两款核心产品DB-1303/BNT323（HER2 ADC）及DB-1311/BNT324（B7-H3...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"DUALITYBIO-B 2025年度：营收约18.52亿元小幅下滑，净亏损增至25.95亿元，股本由负转正","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630889387","title":"DualityBio publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630889387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630889387?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:24","pubTimestamp":1777202666,"startTime":"0","endTime":"0","summary":"DualityBio released its 2025 environmental, social, and governance report, highlighting 2025 revenue of about RMB 1.85 billion.Report flagged commercialization progress, with one product expected to be launched.Pipeline update showed 13 proprietary ADC candidates, including 10 clinical-stage assets.Global development footprint included 10 clinical trials across more than 230 centers in 17 countries, with over 3,200 patients enrolled.Climate disclosure expanded to first-time Scope 3 carbon accounting in 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on Apri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL7HtJsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165196464","title":"HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165196464","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165196464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:32","pubTimestamp":1776915127,"startTime":"0","endTime":"0","summary":"HK biotech stocks fell. Akeso down 12%; Remegen, Zai Lab, KeyMed and Junshi down 7%; Lepu and Innocare down 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","02269","09688","06606","09926","02359","09606","09995","02137","02268","02162","09966","06978","01672","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124678664","title":"China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1124678664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124678664?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:39","pubTimestamp":1776321543,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report stating that on April 14th, the General Office of the State Council issued the \"Several Opinions on Improving the Drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1589","LU0348735423.USD","BK1574","LU2488822045.USD","BK1161","HK0000500386.USD","BK1191","06990","BK1583","HK0000252152.HKD","01801","LU0348827113.USD","09606","LU0307460666.USD","LU0417516902.SGD","BK1500","BK1588","LU1770034418.SGD","LU1023057109.AUD","LU2097828474.EUR","LU1794554557.SGD","LU2097828805.USD","LU0348784397.USD","09926","LU2778985437.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU2328871848.SGD","LU0561508036.HKD","LU1969619763.USD","IE00BPRC5H50.USD","HK0000165453.HKD","LU0359201612.USD","LU0540923850.HKD","LU2543165471.USD","LU1961090484.USD","LU0588546209.SGD","LU2097828714.EUR","LU0455707207.USD","LU0359201885.HKD","LU0417516571.SGD","06978","LU2399975544.HKD","LU0359202008.SGD","HK0000252160.HKD","LU0417516738.SGD","LU0502904849.HKD","LU1719994722.HKD","LU2476274308.USD","LU0348783233.USD","LU2097828557.USD","LU2097828631.EUR","LU1303224171.USD","06160","LU0196878994.USD","LU1720050803.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IPOS","LU0348766576.USD","LU2242644610.SGD","LU0348767384.USD","01276","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170833307","title":"Stock Track | DUALITYBIO-B Soars 5.02% Intraday on STAR Market Listing Plan Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1170833307","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170833307?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:33","pubTimestamp":1776216839,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B's stock price surged 5.02% during intraday trading on Wednesday, following the company's announcement of plans to pursue a secondary listing on China's STAR Market. The biopharmaceutical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172774249","title":"DualityBio-B Advances Global ADC Leadership with Dual Capital Platform Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1172774249","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172774249?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:03","pubTimestamp":1776211396,"startTime":"0","endTime":"0","summary":"On the evening of April 13, leading ADC company DualityBio-B (09606) announced that its board of directors has approved a plan to issue RMB-denominated shares and list on the STAR Market. The company...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","BK4080","ADC","BK4231","BK1161","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154397574","title":"DualityBio Convenes 29 April 2026 EGM to Approve RMB Share Issue and Corporate Governance Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1154397574","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154397574?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:21","pubTimestamp":1776172912,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio) has issued a proxy form ahead of an Extraordinary General Meeting (EGM) scheduled for 9:00 a.m. on 29 April 2026 at its Shanghai headquarters, Board Room,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627441870","title":"Duality Biotherapeutics announces extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627441870","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627441870?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:04","pubTimestamp":1776171885,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics will hold an extraordinary general meeting in Shanghai on April 29, 2026.Shareholders will vote on a proposed RMB share issue, including a specific mandate to issue up to 15,779,190 RMB shares.Resolutions also cover board authorizations tied to the RMB share issue, use of proceeds, accumulated loss arrangements, and post-issue price stabilization and dividend return plans.Meeting agenda includes adoption of new procedural rules for shareholder meetings and board meetings, effective upon listing of RMB shares on the Sci-Tech Board.A special resolution seeks approval of amendments to articles of association, conditional on passage of the RMB share issue mandate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duali","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL9cLHyq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","BK1161","HK0000500386.USD","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189252112","title":"DualityBio Proposes Up to RMB 6.75 Billion STAR Market IPO; Shareholders to Vote on 29 April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1189252112","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189252112?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:04","pubTimestamp":1776171848,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics Inc. (DualityBio) has called an extraordinary general meeting for 29 April 2026 to seek approval for a domestic initial public offering of up to 15.78 million RMB-denominated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627451061","title":"BRIEF-Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2627451061","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627451061?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:16","pubTimestamp":1776093384,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech BoardApril 13  - Duality Biotherapeutics 9606.HK:APPROVED PROPOSED RMB SHARE ISSUE ON SCI-TECH BOARDPROPOSES TO ISSUE NOT MORE THAN 15.8 MILLION RMB SHARESPROCEEDS RAISED FROM RMB SHARE ISSUE WILL BE USED FOR INNOVATIVE DRUG RESEARCH, OTHERSFurther company coverage: 9606.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","BK1161","HK0000500386.USD","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172062646","title":"DUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1172062646","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172062646?lang=en_us&edition=fundamental","pubTime":"2026-04-13 22:50","pubTimestamp":1776091843,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","MCNHmain","09606","HK0000252152.HKD","HK0000500386.USD","159982","CYB","BK1161","CNHmain","MUCmain","HK0000252160.HKD","LU2543165471.USD","UCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627513644","title":"Duality Biotherapeutics Inc - Proceeds Raised From RMB Share Issue Will Be Used for Innovative Drug Research, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2627513644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627513644?lang=en_us&edition=fundamental","pubTime":"2026-04-13 22:41","pubTimestamp":1776091281,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0VT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627513354","title":"Duality Biotherapeutics Inc - Approved Proposed RMB Share Issue on Sci-Tech Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2627513354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627513354?lang=en_us&edition=fundamental","pubTime":"2026-04-13 22:41","pubTimestamp":1776091281,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","HK0000500386.USD","BK1161","09606","HK0000252160.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627451336","title":"Duality Biotherapeutics Inc - Proposes to Issue Not More Than 15.8 Mln RMB Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627451336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627451336?lang=en_us&edition=fundamental","pubTime":"2026-04-13 22:41","pubTimestamp":1776091281,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0VT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","09606","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626219475","title":"DualityBio says China NMPA accepts trastuzumab pamirtecan breast cancer BLA for review","url":"https://stock-news.laohu8.com/highlight/detail?id=2626219475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626219475?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:24","pubTimestamp":1775820278,"startTime":"0","endTime":"0","summary":"DualityBio said China NMPA accepted for review its BLA for trastuzumab pamirtecan  in HER2-positive unresectable or metastatic breast cancer.Filing seeks approval as second-line therapy versus Roche’s Kadcyla , based on interim Phase III data showing a statistically significant progression-free survival benefit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL9PtyL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","09606","BK1161","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":136,"code":"91000000","status":"200"}]}}